Expansion of plant facility eyed, Janssen Korea says

Published: 2003-02-07 06:56:00

Updated: 2003-02-07 06:56:00

Although many foreign-invested pharmaceutical firms are in the process of withdrawing their plants from Korea, Janssen Korea is scheduled to expand its plant at Hwasung of Kyunggi Province in the first half of this year, as part of increasing the production rate of locally marketed items in Korea...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK